These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10487478)

  • 21. Prospective, open-label, add-on study of lamotrigine in 56 children with intractable generalized epilepsy.
    Farrell K; Connolly MB; Munn R; Peng S; MacWilliam LM
    Pediatr Neurol; 1997 Apr; 16(3):201-5. PubMed ID: 9165509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lamotrigine-induced seizure aggravation and negative myoclonus in idiopathic rolandic epilepsy.
    Cerminara C; Montanaro ML; Curatolo P; Seri S
    Neurology; 2004 Jul; 63(2):373-5. PubMed ID: 15277643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epileptic encephalopathy.
    Dulac O
    Epilepsia; 2001; 42 Suppl 3():23-6. PubMed ID: 11520318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic interaction of lamotrigine and sodium valproate in intractable myoclonic epilepsy.
    Ferrie CD; Panayiotopoulos CP
    Seizure; 1994 Jun; 3(2):157-9. PubMed ID: 8081644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversible aphasic disorder induced by lamotrigine in atypical benign childhood epilepsy.
    Battaglia D; Iuvone L; Stefanini MC; Acquafondata C; Lettori D; Chiricozzi F; Pane M; Mittica A; Guzzetta F
    Epileptic Disord; 2001 Dec; 3(4):217-22. PubMed ID: 11844717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A survey of lamotrigine and vigabatrin treatment in children with severe epilepsy.
    Schapel GJ; Wallace SJ; Gordon GS
    Seizure; 1997 Dec; 6(6):479-83. PubMed ID: 9530945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study.
    Coppola G; Auricchio G; Federico R; Carotenuto M; Pascotto A
    Epilepsia; 2004 Sep; 45(9):1049-53. PubMed ID: 15329068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of lamotrigine (LTG) monotherapy.
    Panayiotopoulos CP
    Epilepsia; 2000 Mar; 41(3):357-9. PubMed ID: 10714412
    [No Abstract]   [Full Text] [Related]  

  • 29. Antiepileptic drugs in development: prospects for the near future.
    Leppik IE
    Epilepsia; 1994; 35 Suppl 4():S29-40. PubMed ID: 8174517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of lamotrigine in juvenile myoclonic epilepsy.
    Buchanan N
    Seizure; 1996 Jun; 5(2):149-51. PubMed ID: 8795132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levetiracetam-induced myoclonic status epilepticus in myoclonic-astatic epilepsy: a case report.
    Kröll-Seger J; Mothersill IW; Novak S; Sälke-Kellermann RA; Krämer G
    Epileptic Disord; 2006 Sep; 8(3):213-8. PubMed ID: 16987744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paradoxic reaction to lamotrigine in a child with benign focal epilepsy of childhood with centrotemporal spikes.
    Catania S; Cross H; de Sousa C; Boyd S
    Epilepsia; 1999 Nov; 40(11):1657-60. PubMed ID: 10565596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lamotrigine: clinical experience in 93 patients with epilepsy.
    Buchanan N
    Acta Neurol Scand; 1995 Jul; 92(1):28-32. PubMed ID: 7572057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generalized myoclonus and spasticity induced by lamotrigine toxicity: a case report and literature review.
    Algahtani HA; Aldarmahi AA; Al-Rabia MW; Almalki WH; Bryan Young G
    Clin Neuropharmacol; 2014; 37(2):52-4. PubMed ID: 24614666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effectiveness and role of lamotrigine in the paradigm shift towards new antiepileptic drugs: a therapeutic strategy proposed after an investigation of a large number of cases at a single hospital].
    Yamamoto T; Yamazoe T; Fujimoto A; Kobayashi R; Yokota T; Okanishi T; Uchiyama G; Ohashi T; Tanaka T; Enoki H
    Brain Nerve; 2014 Jan; 66(1):59-69. PubMed ID: 24371132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
    Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Vigabatrin and lamotrigin: experiences with 2 new anticonvulsants in the Swiss epilepsy clinic].
    Vogt H; Krämer G
    Schweiz Med Wochenschr; 1995 Jan; 125(4):125-32. PubMed ID: 7878401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lamotrigine monotherapy for newly diagnosed typical absence seizures in children.
    Holmes GL; Frank LM; Sheth RD; Philbrook B; Wooten JD; Vuong A; Kerls S; Hammer AE; Messenheimer J
    Epilepsy Res; 2008 Dec; 82(2-3):124-32. PubMed ID: 18778916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term effectiveness of ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy.
    Hwang H; Kim H; Kim SH; Kim SH; Lim BC; Chae JH; Choi JE; Kim KJ; Hwang YS
    Brain Dev; 2012 May; 34(5):344-8. PubMed ID: 21893390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lamictal (lamotrigine) monotherapy for typical absence seizures in children.
    Frank LM; Enlow T; Holmes GL; Manasco P; Concannon S; Chen C; Womble G; Casale EJ
    Epilepsia; 1999 Jul; 40(7):973-9. PubMed ID: 10403222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.